Amy DuRoss - Mar 8, 2024 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role: Director
Signature: /s/ Amy DuRoss
Stock symbol: BLFS
Transactions as of: Mar 8, 2024
Transactions value $: -$189,541
Form type: 4
Date filed: 3/13/2024, 06:37 PM
Previous filing: Nov 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BLFS	Common Stock	Award		+11.3K	+38.34%		40.6K	Mar 8, 2024	Direct	F1
transaction	BLFS	Common Stock	Sale	-$103K	-6.14K	-15.09%	$16.86	34.5K	Mar 12, 2024	Direct	F2
transaction	BLFS	Common Stock	Sale	-$86.1K	-5.07K	-14.68%	$17.00	29.4K	Mar 13, 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the "2023 Plan") and fully vests on the first anniversary of the grant date.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.60 to $17.11, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Content

The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the "2023 Plan") and fully vests on the first anniversary of the grant date.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.60 to $17.11, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.